Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/1998
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021194A1 Novel biphenyl dicarboxylic acid derivatives and process for preparing them
05/22/1998WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
05/22/1998WO1998020906A2 Treatment of diabetes with transcription factor gene
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020883A1 Use of pvp or povidone for reducing bowel distension
05/22/1998WO1998020862A1 Immediate wettability water soluble film or water soluble layer for oral application
05/22/1998WO1998020839A1 Biologically resorbable polymerization products made of binding agent systems which can be hardened by radiation
05/22/1998WO1998020838A1 Preparation for dental treatment
05/22/1998CA2539815A1 Solvent-free crystal of benzimidazole derivative and its use
05/22/1998CA2271794A1 Preparation for dental treatment
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/22/1998CA2270943A1 Use of pvp or povidone for reducing bowel distension
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842276A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
05/20/1998EP0842274A1 Human mp52 arg protein
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0842161A1 4,5-diaryl oxazole derivatives
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841933A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841911A1 Calcium-containing agent for intestinal phosphate binding and process for producing it
05/20/1998EP0841903A1 Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
05/20/1998CN1182435A Casein Phosphopeptide, casein containing same and process for the preparation thereof
05/20/1998CN1181947A Clystering liquid for curing lupus colonitis
05/19/1998US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them
05/19/1998US5753673 Quinolinecarboxylic acid derivatives
05/19/1998US5753663 5ht2c antagonist, useful for treating anxiety, pain, obsessive compulsive disorder, alcoholism, depression, migraine, sleep disorder, anorexia nervosa and priapism
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753265 Multiple unit pharmaceutical preparation
05/14/1998WO1998020142A1 Notch
05/14/1998WO1998020132A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998WO1998020040A1 Novel histamine h2 receptor
05/14/1998WO1998020011A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
05/14/1998WO1998020010A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019996A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998WO1998019687A1 Natural teas for taking off the effects of drink and process for the production thereof
05/14/1998WO1998019669A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998DE19646392A1 Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht Preparation with a pressure-sensitive adhesive for use in the oral cavity to the mucosa, pharmaceuticals or cosmetics for metering layer containing
05/14/1998CA2271013A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998CA2270909A1 Novel histamine h2 receptor
05/14/1998CA2270520A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998CA2270173A1 Tumor-associated kazal inhibitor with pec-60 homology
05/14/1998CA2269858A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840735A1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
05/13/1998EP0840732A1 Substituted benzolactam compounds as substance p antagonists
05/13/1998EP0840728A1 Heteroaryl diol acids as leukotriene antagonists
05/13/1998EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840615A2 Chemokine binding protein and methods of use therefor
05/13/1998EP0840607A1 Novel medical use
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma
05/13/1998EP0628032B1 Quinazolinone antianginal agents
05/13/1998EP0623118B1 Carbamate derivatives and their use in medicine
05/13/1998CN1181753A Novel substituted piperazine derivatives having tachyknin receptor antagonists activity
05/13/1998CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
05/13/1998CN1181691A Oral compsn. for animals
05/13/1998CN1181259A Powder for eliminating infantile malnutrition of child and its prepn. method
05/13/1998CN1181249A Paste for treating child diarrhoea
05/12/1998US5750701 Heterocyclic ethanolamine derivatives with β-adrenoreceptor agonistic activity
05/12/1998US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems
05/12/1998US5750552 Antiulcer agents
05/12/1998US5750546 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
05/12/1998US5750539 Antiasthmatics
05/12/1998US5750531 Pyrimidine derivatives and processes for the preparation thereof
05/12/1998US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998CA2030718C Tricyclic compounds
05/07/1998WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018798A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
05/07/1998WO1998018788A1 Piperazino derivatives as neurokinin antagonists
05/07/1998WO1998018786A1 Constrained somatostatin agonists and antagonists
05/07/1998WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists
05/07/1998WO1998018784A1 Process for preparation of pyrimidine derivatives
05/07/1998WO1998018761A1 Substituted arylalkylamines as neurokinin antagonists
05/07/1998WO1998018487A1 Prophylactic/remedial agent
05/07/1998WO1998018479A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
05/07/1998WO1998009985A3 Anti-inflammatory peptides and uses thereof
05/07/1998WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 1258